Approval · Notice of Compliance 30440 · 2023
CYPROTERONE: Notice of Compliance 30440
Issued March 31, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30440
- Date
- March 31, 2023
- Company
- AA Pharma Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph. Update to the Package Insert
- Canadian reference product
- ANDROCUR (Berlex Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CYPROTERONE | Not yet assigned | — |
Medicinal ingredients
- CYPROTERONE ACETATE 50 MG per TAB